Sangamo Therapeutics's Earnings Outlook

Sangamo Therapeutics's Earnings Outlook

Sangamo Therapeutics SGMO is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement.

Analysts estimate that Sangamo Therapeutics will report an earnings per share (EPS) of $-0.35.

Sangamo Therapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.06, which was followed by a 9.01% increase in the share price the next day.

Here's a look at Sangamo Therapeutics's past performance and the resulting price change:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.35 -0.31 -0.34 -0.34
EPS Actual -0.29 -0.30 -0.26 -0.33
Price Change % 9.01% -3.72% 3.33% 0.73%

Stock Performance

Shares of Sangamo Therapeutics were trading at $4.39 as of November 01. Over the last 52-week period, shares are down 59.9%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for Sangamo Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-EPEarnings